Loading provider…
Loading provider…
Hematology & Oncology Physician in Cincinnati, OH
NPI: 1285981498Primary Practice Location
THE JEWISH HOSPITAL-MERCY HEALTH
4777 E Galbraith Rd, Cincinnati, OH
Primary Employer
Cincinnato PET Scan
ohcare.com
HQ Phone
Get MD Akash's Phone Numberphone_androidMobile
Get MD Akash's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardAR State Medical License
OH State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 145 | 223 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 99 | 241 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 54 | 332 |
| 4 | 99223Initial hospital inpatient care, typically 70 minutes per day | 25 | 29 |
| 5 | 99221Initial hospital inpatient care, typically 30 minutes per day | 13 | 14 |
Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host disease.
Authors: Pablo Okhuysen, Elizabeth Shpall, Doris Ponce, Jeffrey Molldrem, Jennifer Wargo, Samuel Shelburne, Katherine King, Saira Ahmed, Richard Champlin, Margaret Conner, Robert Jenq, Amin Alousi, Jonathan Peled, Rohtesh Mehta
Journal: Cell Host Microbe
Publication Date: 2024-08-29
Voriconazole photosensitivity causes apparent graft-versus-host disease exacerbation.
Authors: Audrey Scholoff, Rammurti Kamble, George Carrum
Journal: Bone Marrow Transplant
Publication Date: 2018-08-07
Authors: Jan Burger, Tapan Kadia, Alessandra Ferrajoli, Elias Jabbour, Richard Champlin, Issa Khouri, Hagop Kantarjian, Nitin Jain, Leonard Medeiros, William Wierda
Journal: Leuk Lymphoma
Publication Date: 2022-02-27
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, BIOLOGICAL: Nivolumab, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, BIOLOGICAL: Pegfilgrastim, OTHER: Quality-of-Life Assessment, RADIATION: Radiation Therapy, DRUG: Dacarbazine, DRUG: Brentuximab Vedotin, PROCEDURE: Computed Tomography, BIOLOGICAL: Filgrastim, DRUG: Vinblastine Sulfate, DRUG: Doxorubicin Hydrochloride